Mitsubishi UFJ Trust & Banking’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-147,814
Closed -$8.27M 1117
2023
Q4
$8.27M Sell
147,814
-24,890
-14% -$1.08M 0.02% 594
2023
Q3
$7.12M Sell
172,704
-1,146
-0.7% -$59.6K 0.02% 618
2023
Q2
$9.71M Sell
173,850
-7,540
-4% -$408K 0.02% 560
2023
Q1
$10.1M Buy
181,390
+290
+0.2% +$13.5K 0.02% 546
2022
Q4
$6.6M Sell
181,100
-5,740
-3% -$188K 0.02% 629
2022
Q3
$5.32M Hold
186,840
0.01% 650
2022
Q2
$8.46M Sell
186,840
-37,904
-17% -$1.97M 0.02% 581
2022
Q1
$17.1M Buy
224,744
+796
+0.4% +$69.6K 0.04% 441
2021
Q4
$33.4M Sell
223,948
-20,739
-8% -$3.18M 0.07% 294
2021
Q3
$35.6M Sell
244,687
-5,506
-2% -$945K 0.08% 275
2021
Q2
$49M Buy
250,193
+212,478
+563% +$38.5M 0.1% 236
2021
Q1
$6.81M Sell
37,715
-5,552
-13% -$959K 0.02% 683
2020
Q4
$6.13M Buy
+43,267
New +$6.28M 0.01% 715

Other funds holding TXG

Mitsubishi UFJ Trust & Banking's TXG Position: Q1 2024 in Review

Mitsubishi UFJ Trust & Banking sold out of 10x Genomics (TXG) in Q1 2024, closing a stake of 147,814 shares — an estimated $8.27M sold.

Mitsubishi UFJ Trust & Banking first reported a position in TXG in Q4 2020 and held it in 13 quarters. The position peaked at $49M in Q2 2021. 290 funds tracked by Wall St. Rank hold TXG as of Q1 2024.

  • Mitsubishi UFJ Trust & Banking reported no remaining 10x Genomics position as of Q1 2024 after selling out during the quarter.
  • Mitsubishi UFJ Trust & Banking sold 147,814 10x Genomics shares in Q1 2024, an estimated $8.27M.
  • Mitsubishi UFJ Trust & Banking first reported a position in 10x Genomics in Q4 2020 and held it in 13 quarters.
  • Mitsubishi UFJ Trust & Banking's 10x Genomics position peaked at $49M in Q2 2021.
  • 290 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2024.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q1 2024, filed 10 May 2024.